| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3181780 | Actas Dermo-Sifiliográficas | 2007 | 7 Pages |
Abstract
Actinic keratosis is currently considered not to be a precursor of squamous cell carcinoma but, rather, an initial stage of the disease. Furthermore, the incidence of both squamous cell carcinoma and basal cell carcinoma continues to increase. Topical drugs are now becoming widely used in the therapeutic management of nonmelanoma skin cancer and its precursor lesions. Here, we review the various topical drugs that are currently available and discuss their advantages and drawbacks. Therapeutic options include retinoids, 5-fluoracil, diclofenac, imiquimod, and photodynamic therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M.V. Barrera, E. Herrera,